Cargando…

Prevention and Treatment of Carbapenem-Resistant Organism Bacilli from Liver Transplantation Donors – Single Center Experience

OBJECTIVE: To evaluate and explore the effectiveness of the new prevention and control measures for the donor-derived infection (DDI) associated with CRO after liver transplantation. METHODS: The data of 120 organ donors and recipients from January 2018 to May 2020 were retrospectively analyzed at T...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Li, Fu, Zhi, Wang, Menglong, Wang, Xin, Wang, Lu, Li, Guangming, Lin, Dongdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747530/
https://www.ncbi.nlm.nih.gov/pubmed/35023935
http://dx.doi.org/10.2147/IDR.S346494
_version_ 1784630855654703104
author He, Li
Fu, Zhi
Wang, Menglong
Wang, Xin
Wang, Lu
Li, Guangming
Lin, Dongdong
author_facet He, Li
Fu, Zhi
Wang, Menglong
Wang, Xin
Wang, Lu
Li, Guangming
Lin, Dongdong
author_sort He, Li
collection PubMed
description OBJECTIVE: To evaluate and explore the effectiveness of the new prevention and control measures for the donor-derived infection (DDI) associated with CRO after liver transplantation. METHODS: The data of 120 organ donors and recipients from January 2018 to May 2020 were retrospectively analyzed at The Liver Transplantation Center of Beijing Youan Hospital, Capital Medical University, to investigate the epidemiological status of CRO in donors. The cases were divided into two groups. The implemented group was treated according to the execution of a clustered CRO prevention and control measure based on active screening combined with early initiation of prophylactic/therapeutic administration of antibiotics. The effectiveness of the prevention and control measures was evaluated by comparing the length of postoperative ICU stay, total postoperative length of hospital stay, duration of ventilator use, duration of restricted antibiotics use, the incidence of DDI, incidence and composition distribution of DDI-related CRO, and incidence of severe DDI-relevant adverse events between the two groups. RESULTS: There was a high detection rate of 39.32% (105 strains) of drug-resistant bacteria in the donors. Fifty-six strains of CRO were detected. Participants in group B, which implemented the new prevention and control measures, were transferred out of the ICU sooner (P = 0.023), used fewer restrictive antibiotics (P = 0.003), and were discharged more quickly (P = 0.013) than those in group A. Postoperative DDI incidences (P = 0.113) and severe DDI-related adverse events were not statistically different between the two groups (P = 0.062). CR-Kp-related DDI was less common in group B (P = 0.021). CONCLUSION: The situation of donor-derived drug-resistant bacterial infections remains critical. The clustered prevention and control measures for CRO based on active screening combined with early initiation of prophylactic/therapeutic application of antibiotics would be beneficial.
format Online
Article
Text
id pubmed-8747530
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87475302022-01-11 Prevention and Treatment of Carbapenem-Resistant Organism Bacilli from Liver Transplantation Donors – Single Center Experience He, Li Fu, Zhi Wang, Menglong Wang, Xin Wang, Lu Li, Guangming Lin, Dongdong Infect Drug Resist Original Research OBJECTIVE: To evaluate and explore the effectiveness of the new prevention and control measures for the donor-derived infection (DDI) associated with CRO after liver transplantation. METHODS: The data of 120 organ donors and recipients from January 2018 to May 2020 were retrospectively analyzed at The Liver Transplantation Center of Beijing Youan Hospital, Capital Medical University, to investigate the epidemiological status of CRO in donors. The cases were divided into two groups. The implemented group was treated according to the execution of a clustered CRO prevention and control measure based on active screening combined with early initiation of prophylactic/therapeutic administration of antibiotics. The effectiveness of the prevention and control measures was evaluated by comparing the length of postoperative ICU stay, total postoperative length of hospital stay, duration of ventilator use, duration of restricted antibiotics use, the incidence of DDI, incidence and composition distribution of DDI-related CRO, and incidence of severe DDI-relevant adverse events between the two groups. RESULTS: There was a high detection rate of 39.32% (105 strains) of drug-resistant bacteria in the donors. Fifty-six strains of CRO were detected. Participants in group B, which implemented the new prevention and control measures, were transferred out of the ICU sooner (P = 0.023), used fewer restrictive antibiotics (P = 0.003), and were discharged more quickly (P = 0.013) than those in group A. Postoperative DDI incidences (P = 0.113) and severe DDI-related adverse events were not statistically different between the two groups (P = 0.062). CR-Kp-related DDI was less common in group B (P = 0.021). CONCLUSION: The situation of donor-derived drug-resistant bacterial infections remains critical. The clustered prevention and control measures for CRO based on active screening combined with early initiation of prophylactic/therapeutic application of antibiotics would be beneficial. Dove 2022-01-06 /pmc/articles/PMC8747530/ /pubmed/35023935 http://dx.doi.org/10.2147/IDR.S346494 Text en © 2022 He et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
He, Li
Fu, Zhi
Wang, Menglong
Wang, Xin
Wang, Lu
Li, Guangming
Lin, Dongdong
Prevention and Treatment of Carbapenem-Resistant Organism Bacilli from Liver Transplantation Donors – Single Center Experience
title Prevention and Treatment of Carbapenem-Resistant Organism Bacilli from Liver Transplantation Donors – Single Center Experience
title_full Prevention and Treatment of Carbapenem-Resistant Organism Bacilli from Liver Transplantation Donors – Single Center Experience
title_fullStr Prevention and Treatment of Carbapenem-Resistant Organism Bacilli from Liver Transplantation Donors – Single Center Experience
title_full_unstemmed Prevention and Treatment of Carbapenem-Resistant Organism Bacilli from Liver Transplantation Donors – Single Center Experience
title_short Prevention and Treatment of Carbapenem-Resistant Organism Bacilli from Liver Transplantation Donors – Single Center Experience
title_sort prevention and treatment of carbapenem-resistant organism bacilli from liver transplantation donors – single center experience
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747530/
https://www.ncbi.nlm.nih.gov/pubmed/35023935
http://dx.doi.org/10.2147/IDR.S346494
work_keys_str_mv AT heli preventionandtreatmentofcarbapenemresistantorganismbacillifromlivertransplantationdonorssinglecenterexperience
AT fuzhi preventionandtreatmentofcarbapenemresistantorganismbacillifromlivertransplantationdonorssinglecenterexperience
AT wangmenglong preventionandtreatmentofcarbapenemresistantorganismbacillifromlivertransplantationdonorssinglecenterexperience
AT wangxin preventionandtreatmentofcarbapenemresistantorganismbacillifromlivertransplantationdonorssinglecenterexperience
AT wanglu preventionandtreatmentofcarbapenemresistantorganismbacillifromlivertransplantationdonorssinglecenterexperience
AT liguangming preventionandtreatmentofcarbapenemresistantorganismbacillifromlivertransplantationdonorssinglecenterexperience
AT lindongdong preventionandtreatmentofcarbapenemresistantorganismbacillifromlivertransplantationdonorssinglecenterexperience